Ali Faraz

Chief Executive Officer, DirectorTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Aug 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2026Sell(S)6K$0.71$4K434K
Aug 17, 2026Sell(S)4K$0.71$3K430K
Aug 17, 2026Sell(S)5K$0.71$4K425K
Aug 17, 2026Sell(S)7K$0.71$5K418K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-354518) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.